Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Sep;119(2):315–320. doi: 10.1111/j.1476-5381.1996.tb15988.x

Inhibition of Ca(2+)-sensitive K+ currents in NG 108-15 cells by substance P and related tachykinins.

S Phenna 1, E Carpenter 1, C Peers 1, S Maudsley 1, J P Gent 1
PMCID: PMC1915845  PMID: 8886415

Abstract

1. The whole-cell patch-clamp technique was used to investigate the actions of substance P and other agonists at neurokinin (NK) receptors on voltage-gated K+ and Ca+ channel currents in undifferentiated mouse neuroblastoma x rat glioma NG 108-15 cells. 2. Both substance P (0.3-30 microM) and the NK1 receptor selective agonist GR73632 (10 nM-10 microM) caused concentration-dependent inhibition of K+ currents. GR64349 and senktide (agonists at NK2 and NK3 receptors respectively) also inhibited K+ currents, but only at concentrations which were several orders of magnitude greater than GR73632, suggesting that current inhibition was mediated via NK1 receptors. 3. Substance P and GR73632 were without effect on residual K+ currents recorded in the presence of extracellular Co2+ (4 mM) to abolish the Ca(2+)-sensitive component (IKca) of the K+ current. Ca2+ channel currents, recorded with either Ba2+ or Ca2+ as charge carrier, were unaffected by NK1, NK2 and NK3 receptor ligands. 4. Iontophoretic application of GR73632 produced a current-dependent reduction of K+ currents. In the presence of the non-peptide NK1 antagonists, CP-99,994 and RP67580, and the peptide antagonist, GR82334, the current-response relationship was reversibly shifted to the right. This indicates that the response is mediated by NK1 receptors. 5. Our results indicate that activation of NK1 receptors leads to the selective inhibition of IKca in undifferentiated NG 108-15 cells.

Full text

PDF
318

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Advenier C., Rouissi N., Nguyen Q. T., Emonds-Alt X., Breliere J. C., Neliat G., Naline E., Regoli D. Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist. Biochem Biophys Res Commun. 1992 May 15;184(3):1418–1424. doi: 10.1016/s0006-291x(05)80041-5. [DOI] [PubMed] [Google Scholar]
  3. Anwyl R. Modulation of vertebrate neuronal calcium channels by transmitters. Brain Res Brain Res Rev. 1991 Sep-Dec;16(3):265–281. doi: 10.1016/0165-0173(91)90010-6. [DOI] [PubMed] [Google Scholar]
  4. Barr A. J., Watson S. P. Non-peptide antagonists, CP-96,345 and RP 67580, distinguish species variants in tachykinin NK1 receptors. Br J Pharmacol. 1993 Jan;108(1):223–227. doi: 10.1111/j.1476-5381.1993.tb13466.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beaujouan J. C., Heuillet E., Petitet F., Saffroy M., Torrens Y., Glowinski J. Higher potency of RP 67580, in the mouse and the rat compared with other nonpeptide and peptide tachykinin NK1 antagonists. Br J Pharmacol. 1993 Mar;108(3):793–800. doi: 10.1111/j.1476-5381.1993.tb12880.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Beresford I. J., Birch P. J., Hagan R. M., Ireland S. J. Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345. Br J Pharmacol. 1991 Oct;104(2):292–293. doi: 10.1111/j.1476-5381.1991.tb12423.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Berridge M. J., Irvine R. F. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature. 1984 Nov 22;312(5992):315–321. doi: 10.1038/312315a0. [DOI] [PubMed] [Google Scholar]
  8. Bley K. R., Tsien R. W. Inhibition of Ca2+ and K+ channels in sympathetic neurons by neuropeptides and other ganglionic transmitters. Neuron. 1990 Mar;4(3):379–391. doi: 10.1016/0896-6273(90)90050-p. [DOI] [PubMed] [Google Scholar]
  9. Brown D. A., Higashida H. Inositol 1,4,5-trisphosphate and diacylglycerol mimic bradykinin effects on mouse neuroblastoma x rat glioma hybrid cells. J Physiol. 1988 Mar;397:185–207. doi: 10.1113/jphysiol.1988.sp016995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Demolle D., Boeynaems J. M. Cholera and pertussis toxins amplify prostacyclin synthesis in aortic smooth muscle cells. Br J Pharmacol. 1989 Nov;98(3):717–720. doi: 10.1111/j.1476-5381.1989.tb14597.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Garret C., Carruette A., Fardin V., Moussaoui S., Peyronel J. F., Blanchard J. C., Laduron P. M. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10208–10212. doi: 10.1073/pnas.88.22.10208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gitter B. D., Waters D. C., Bruns R. F., Mason N. R., Nixon J. A., Howbert J. J. Species differences in affinities of non-peptide antagonists for substance P receptors. Eur J Pharmacol. 1991 May 17;197(2-3):237–238. doi: 10.1016/0014-2999(91)90532-u. [DOI] [PubMed] [Google Scholar]
  13. Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981 Aug;391(2):85–100. doi: 10.1007/BF00656997. [DOI] [PubMed] [Google Scholar]
  14. Hamprecht B. Structural, electrophysiological, biochemical, and pharmacological properties of neuroblastoma-glioma cell hybrids in cell culture. Int Rev Cytol. 1977;49:99–170. doi: 10.1016/s0074-7696(08)61948-8. [DOI] [PubMed] [Google Scholar]
  15. Helke C. J., Krause J. E., Mantyh P. W., Couture R., Bannon M. J. Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms. FASEB J. 1990 Apr 1;4(6):1606–1615. [PubMed] [Google Scholar]
  16. Kasai H., Neher E. Dihydropyridine-sensitive and omega-conotoxin-sensitive calcium channels in a mammalian neuroblastoma-glioma cell line. J Physiol. 1992 Mar;448:161–188. doi: 10.1113/jphysiol.1992.sp019035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Konishi S., Otsuka M. Excitatory action of hypothalamic substance P on spinal motoneurones of newborn rats. Nature. 1974 Dec 20;252(5485):734–735. doi: 10.1038/252734a0. [DOI] [PubMed] [Google Scholar]
  18. Maggi C. A., Patacchini R., Rovero P., Giachetti A. Tachykinin receptors and tachykinin receptor antagonists. J Auton Pharmacol. 1993 Feb;13(1):23–93. doi: 10.1111/j.1474-8673.1993.tb00396.x. [DOI] [PubMed] [Google Scholar]
  19. Medeiros M. dos S., Balmforth A. J., Vaughan P. F., Turner A. J. Hydrolysis of atrial and brain natriuretic peptides by the human astrocytoma clone D384 and the neuroblastoma line SH-SY5Y. Neuroendocrinology. 1991 Sep;54(3):295–302. doi: 10.1159/000125891. [DOI] [PubMed] [Google Scholar]
  20. Murase K., Ryu P. D., Randić M. Tachykinins modulate multiple ionic conductances in voltage-clamped rat spinal dorsal horn neurons. J Neurophysiol. 1989 Apr;61(4):854–865. doi: 10.1152/jn.1989.61.4.854. [DOI] [PubMed] [Google Scholar]
  21. Nakajima Y., Tsuchida K., Negishi M., Ito S., Nakanishi S. Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells. J Biol Chem. 1992 Feb 5;267(4):2437–2442. [PubMed] [Google Scholar]
  22. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature. 1984 Apr 19;308(5961):693–698. doi: 10.1038/308693a0. [DOI] [PubMed] [Google Scholar]
  23. Peers C., Lang B., Newsom-Davis J., Wray D. W. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line. J Physiol. 1990 Feb;421:293–308. doi: 10.1113/jphysiol.1990.sp017945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Reeve H. L., Peers C. Blockade of delayed rectifier K+ currents in neuroblastoma x glioma hybrid (NG 108-15) cells by clofilium, a class III antidysrhythmic agent. Br J Pharmacol. 1992 Feb;105(2):458–462. doi: 10.1111/j.1476-5381.1992.tb14275.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Reiser G., Hamprecht B. Bradykinin causes a transient rise of intracellular Ca2+-activity in cultured neural cells. Pflugers Arch. 1985 Oct;405(3):260–264. doi: 10.1007/BF00582570. [DOI] [PubMed] [Google Scholar]
  26. Rusin K. I., Jiang M. C., Cerne R., Randic M. Interactions between excitatory amino acids and tachykinins in the rat spinal dorsal horn. Brain Res Bull. 1993;30(3-4):329–338. doi: 10.1016/0361-9230(93)90261-9. [DOI] [PubMed] [Google Scholar]
  27. Shen K. Z., North R. A. Substance P opens cation channels and closes potassium channels in rat locus coeruleus neurons. Neuroscience. 1992 Sep;50(2):345–353. doi: 10.1016/0306-4522(92)90428-5. [DOI] [PubMed] [Google Scholar]
  28. Snider R. M., Constantine J. W., Lowe J. A., 3rd, Longo K. P., Lebel W. S., Woody H. A., Drozda S. E., Desai M. C., Vinick F. J., Spencer R. W. A potent nonpeptide antagonist of the substance P (NK1) receptor. Science. 1991 Jan 25;251(4992):435–437. doi: 10.1126/science.1703323. [DOI] [PubMed] [Google Scholar]
  29. Spigelman I., Puil E. Substance P actions on sensory neurons. Ann N Y Acad Sci. 1991;632:220–228. doi: 10.1111/j.1749-6632.1991.tb33110.x. [DOI] [PubMed] [Google Scholar]
  30. Stanfield P. R., Nakajima Y., Yamaguchi K. Substance P raises neuronal membrane excitability by reducing inward rectification. Nature. 1985 Jun 6;315(6019):498–501. doi: 10.1038/315498a0. [DOI] [PubMed] [Google Scholar]
  31. Tokimasa T., Tsurusaki M., Akasu T. Chemosensitivity of C-cells in bullfrog dorsal root ganglia to substance P and adenosine 5'-triphosphate. Neurosci Lett. 1993 Dec 12;163(2):169–172. doi: 10.1016/0304-3940(93)90374-t. [DOI] [PubMed] [Google Scholar]
  32. Wormser U., Laufer R., Hart Y., Chorev M., Gilon C., Selinger Z. Highly selective agonists for substance P receptor subtypes. EMBO J. 1986 Nov;5(11):2805–2808. doi: 10.1002/j.1460-2075.1986.tb04571.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES